Selection of recombinant vaccinia viruses on the basis of plaque formation
- PMID: 7607536
- DOI: 10.1016/0378-1119(95)00149-z
Selection of recombinant vaccinia viruses on the basis of plaque formation
Abstract
We developed a procedure for isolation of recombinant vaccinia viruses (re-VV) based solely on plaque formation, without a requirement for specific cell lines, selective medium or special staining. The system consists of two components: (i) a mutant non-plaque-forming VV and (ii) a plasmid vector that, through homologous recombination, can simultaneously introduce a foreign gene and repair mutation in the VV genome. The mutant VV contains a deletion of the vp37 gene, encoding a 37-kDa protein component of the viral outer envelope that is required for efficient viral spread on cell monolayers. The plasmid vector contains a functional vp37, a strong synthetic VV early/late promoter, unique restriction sites for gene insertion, and flanking segments of VV DNA for homologous recombination. Following infection and transfection of cells with the mutant VV and plasmid vector, respectively, re-VV are identified and isolated by their ability to form plaques. To evaluate the system, a re-VV that expresses the gene encoding influenza virus hemagglutinin (HA) was isolated simply by picking visible plaques.
Similar articles
-
Identification of viral membrane proteins required for cell fusion and viral dissemination that are modified during vaccinia virus persistence.Virology. 1994 Jan;198(1):155-68. doi: 10.1006/viro.1994.1018. Virology. 1994. PMID: 8259650
-
Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.J Virol. 1991 Nov;65(11):5910-20. doi: 10.1128/JVI.65.11.5910-5920.1991. J Virol. 1991. PMID: 1920620 Free PMC article.
-
Inducible gene expression from vaccinia virus vectors.Virology. 1990 Jul;177(1):239-50. doi: 10.1016/0042-6822(90)90477-9. Virology. 1990. PMID: 2191497
-
Construction of recombinant vaccinia virus: cloning into the thymidine kinase locus.Methods Mol Biol. 2004;269:31-40. doi: 10.1385/1-59259-789-0:031. Methods Mol Biol. 2004. PMID: 15114005 Review.
-
Heterologous expression of the membrane proteins that control cellular excitability.EXS. 1993;63:31-47. doi: 10.1007/978-3-0348-7265-2_2. EXS. 1993. PMID: 7678529 Review.
Cited by
-
A generic protocol for the affinity-purification of native macromolecular complexes from poxvirus-infected cells.STAR Protoc. 2022 Jan 21;3(1):101116. doi: 10.1016/j.xpro.2021.101116. eCollection 2022 Mar 18. STAR Protoc. 2022. PMID: 35118428 Free PMC article.
-
CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells.J Exp Med. 2005 Feb 7;201(3):349-60. doi: 10.1084/jem.20041542. Epub 2005 Jan 31. J Exp Med. 2005. PMID: 15684323 Free PMC article.
-
Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.J Virol. 2006 Jun;80(12):6106-14. doi: 10.1128/JVI.02665-05. J Virol. 2006. PMID: 16731949 Free PMC article.
-
Glycosylation of immunodominant linear epitopes in the carboxy-terminal region of the caprine arthritis-encephalitis virus surface envelope enhances vaccine-induced type-specific and cross-reactive neutralizing antibody responses.J Virol. 2004 Sep;78(17):9190-202. doi: 10.1128/JVI.78.17.9190-9202.2004. J Virol. 2004. PMID: 15308714 Free PMC article.
-
Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion.Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9859-64. doi: 10.1073/pnas.151098198. Epub 2001 Aug 7. Proc Natl Acad Sci U S A. 2001. PMID: 11493675 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
